These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1385134)
1. Tissue markers in the diagnosis and prognosis of prostatic carcinoma. de Matteis A Eur Urol; 1992; 21 Suppl 1():66-70. PubMed ID: 1385134 [TBL] [Abstract][Full Text] [Related]
3. [Studies on relationship between histology, tumor markers (prostatic acid phosphatase.prostate specific antigen.gamma-seminoprotein.leu-7) and clinical course in prostate cancer]. Tanahashi T; Namba K; Murao T Nihon Hinyokika Gakkai Zasshi; 1990 May; 81(5):680-5. PubMed ID: 1695956 [TBL] [Abstract][Full Text] [Related]
4. [Clinical studies on tumor markers in prostate cancer; the evaluation of PA (prostate specific antigen) and comparison with PAP and gamma-Sm]. Shinoda I; Kuriyama M; Takeuchi T; Takahashi Y; Ban Y; Kawada Y Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):635-42. PubMed ID: 2465430 [No Abstract] [Full Text] [Related]
5. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer]. Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588 [TBL] [Abstract][Full Text] [Related]
6. Serum prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in hemodialysis patients. Sasagawa I; Nakada T; Hashimoto T; Ishigooka M; Kubota Y; Hirano K; Hirano J; Suzuki Y Urol Int; 1992; 48(2):181-3. PubMed ID: 1374977 [TBL] [Abstract][Full Text] [Related]
7. Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen. Fuse H; Umeda K; Mizuno I; Katayama T Int Urol Nephrol; 1991; 23(5):455-63. PubMed ID: 1718922 [TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]. Yoshiki T; Okada K; Oishi K; Yoshida O Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Abrahamsson PA; Lilja H; Falkmer S; Wadström LB Prostate; 1988; 12(1):39-46. PubMed ID: 2450341 [TBL] [Abstract][Full Text] [Related]
10. Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesicles. Aumüller G; Seitz J; Lilja H; Abrahamsson PA; von der Kammer H; Scheit KH Prostate; 1990; 17(1):31-40. PubMed ID: 1696713 [TBL] [Abstract][Full Text] [Related]
11. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein]. Shinoda I Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555 [TBL] [Abstract][Full Text] [Related]
12. [Clinical study of tumor markers in prostatic cancer]. Ishihara Y; Fukagai T; Ohta K; Hiromoto Y; Hiramori M; Torii T; Higaki Y; Imamura K Hinyokika Kiyo; 1990 Apr; 36(4):425-31. PubMed ID: 1696063 [TBL] [Abstract][Full Text] [Related]
13. [Clinical study on PAP, gamma-Sm and PA as tumor markers in prostatic cancer patients]. Ohashi T; Akagi T; Irie S; Obama T; Nasu Y; Tohjoh S; Takeda K; Yoshimoto J; Matsumura Y; Ohmori H Nihon Hinyokika Gakkai Zasshi; 1987 Aug; 78(8):1403-8. PubMed ID: 2449560 [No Abstract] [Full Text] [Related]
14. Beta-microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinoma. Hyakutake H; Sakai H; Yogi Y; Tsuda R; Minami Y; Yushita Y; Kanetake H; Nakazono I; Saito Y Prostate; 1993; 22(4):347-55. PubMed ID: 8497429 [TBL] [Abstract][Full Text] [Related]
15. [Determination of tumor marker doubling time in the patients with prostate cancer relapsed from endocrine therapy]. Akimoto S; Masai M; Kitagawa N; Nakamura T; Shimazaki J Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):450-6. PubMed ID: 7685840 [TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer]. Park YC; Kiwamoto H; Nishioka T; Tsujihashi H; Mitsubayashi S; Matsuura T; Akiyama T; Kurita T; Miyamoto T Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188 [TBL] [Abstract][Full Text] [Related]
17. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers]. Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006 [TBL] [Abstract][Full Text] [Related]
18. [Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue]. Fujino A; Mukai N; Kawakami T; Yokoyama E; Mashimo S; Endo T; Ishibashi A; Koshiba K; Aoki Y; Itoh H Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):541-50. PubMed ID: 1711133 [TBL] [Abstract][Full Text] [Related]
19. Gamma-seminoprotein--a new tumour marker in prostatic cancer? Results of a pilot study. Maier U; Simak R Br J Urol; 1990 May; 65(5):509-12. PubMed ID: 1693867 [TBL] [Abstract][Full Text] [Related]
20. Endometrioid carcinoma of the prostate. The diagnostic value of Leu7 and prostatic specific antigen. Stavropoulos NE; Ioackim-Velogianni E; Sidoni K; Stefanou D; Klouvas G; Pavlidis N Br J Urol; 1993 Mar; 71(3):309-12. PubMed ID: 7682888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]